AIDS drug development wins economics award

Two economists from the University of Chicago won the linkurl:Eugene Garfield Economic Impact of Medical and Health Research Award;http://www.researchamerica.org/outreach/garfieldaward.html this month, given out by the advocacy group Research!America. linkurl:Tomas Philipson;http://harrisschool.uchicago.edu/faculty/web-pages/tomas-philipson.asp and linkurl:Anupam Jena;http://www.rand.org/economics/jena.html looked at how much consumers save and companies profit from the development of life-exten

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Two economists from the University of Chicago won the linkurl:Eugene Garfield Economic Impact of Medical and Health Research Award;http://www.researchamerica.org/outreach/garfieldaward.html this month, given out by the advocacy group Research!America. linkurl:Tomas Philipson;http://harrisschool.uchicago.edu/faculty/web-pages/tomas-philipson.asp and linkurl:Anupam Jena;http://www.rand.org/economics/jena.html looked at how much consumers save and companies profit from the development of life-extending AIDS drugs. Each year, Garfield, who founded __The Scientist__ 21 years ago, gives $5,000 to people who have taken a close look at the impact medical research has on the economy. It's a tough question to answer, as I found out while reporting an linkurl:article;http://www.the-scientist.com/article/display/53302/ on the subject in __The Scientist__ this summer. The estimates of research?s impact on the economy vary widely, but one thing seems to be consistent: its impact appears positive. As Philipson and Jena found, for example, society gained $1.4 trillion from people?s lives being extended by AIDS drugs. The problem the authors find, however, is that companies are taking in just 5% of this "social surplus," raising concerns about the incentives companies have for innovation. You can read their study in the linkurl:Forum for Health Economics and Policy.;http://www.bepress.com/fhep/biomedical_research/3/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery